Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
Transdermal Drug Delivery - Technologies, Markets, and Companies
Benefits of this report:
Up-to-date one-stop information on transdermal drug delivery
Description of 108 companies involved and 95 collaborations in this area
Market analysis 2007-2017/
Market values in major regions
Strategies for developing markets for transdermal drug delivery
A selected bibliography of 170 publications
Text is supplemented by 16 tables and 10 figures
Who should read this report?
Biotechnology companies developing transdermal technologies
Drug delivery companies
Pharmaceutical companies interested in transdermal drug delivery
Pharmaceutical research institutes
Summary
This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers. The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described. Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease. The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2007 to 2017.This market is analyzed according to geographical regions as well.
Table of contents
Basics of Transdermal Drug Delivery
Transdermal Drug Delivery Technologies
Transdermal Therapeutics
Markets for Transdermal Drug Delivery
Companies involved in transdermal drug delivery
References
May 2008. 232 Pages. 16 Tables, 10 Figures, 108 Companies profiled, 95 Alliances listed and 170 References.
Table of Contents
Full Table of Contents (PDF)
Price
PDF Format $2,500.00
Print Format $2,800.00
PDF + Print $3,200.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.